¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contrast sensitivity testing"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • short increment sensitivity index test
    ¹Ì¼¼Áõ°¡°¨¼ö¼ºÁö¼ö°Ë»ç
  • binocular contrast
    ¾ç¾È´ëºñ, µÎ´«´ëºñ
  • barium contrast medium
    ¹Ù·ýÁ¶¿µÁ¦
  • color contrast
    »ö´ëºñ, »ö´ëÁ¶
  • contrast
    1. ´ëÁ¶, ´ëºñ 2. ´ëÁ¶µµ
  • contrast agent
    Á¶¿µÁ¦
  • contrast bath
    ¿Â³Ã±³´ë¸ñ¿å
  • contrast echocardiography
    Á¶¿µ½É(Àå)ÃÊÀ½ÆÄ°Ë»ç, Á¶¿µ½É(Àå)ÃÊÀ½ÆÄ(¼ú)
  • contrast enema
    1. Á¶¿µ°üÀå 2. Á¶¿µ°üÀå¾×
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • contrast material
    Á¶¿µÀç
  • contrast media
    Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sensitivity test
    ¹Î°¨µµ½ÃÇè
  • short increment sensitivity index test
    ¹Ì¼¼Áõ°¡°¨¼ºÁö¼ö°Ë»ç
  • spectral sensitivity
    ºÐ±¤¹Î°¨µµ
  • 3D phase contrast angiography
    »ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
  • contrast agent
    Á¶¿µÁ¦
  • barium contrast medium
    ¹Ù·ýÁ¶¿µÁ¦
  • binocular contrast
    ¾ç¾È´ëºñ, µÎ´«´ëºñ
  • blood oxygenation level dependant contrast
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸´ëÁ¶µµ
  • contrast bath
    ¿Â³Ã±³´ë¸ñ¿å
  • contrast
    ´ëÁ¶
  • color contrast
    »ö´ëºñ, »ö´ëÁ¶
  • contrast echocardiography
    Á¶¿µ½ÉÀåÃÊÀ½ÆÄ°Ë»ç, Á¶¿µ½ÉÃÊÀ½ÆÄ°Ë»ç
  • contrast enema
    Á¶¿µ°üÀå
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast material
    Á¶¿µÀç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin sensitivity
    Àν¶¸°°¨(¼ö)¼º.
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý°ú¹ÎÁõ.
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • radiation sensitivity test, RST
    ¹æ»ç¼±°¨¼ö¼º°Ë»ç
  • receptor sensitivity
    ¼ö¿ëü °¨¼ö¼º
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • CE FAST(contrast enhanced fast acquisition in the st
    ´ëÁ¶µµ Áõ°­ Ç×Á¤»óÅÂÀÇ °í¼Óȹµæ
  • T1 contrast
    T1 ´ëÁ¶µµ
  • T2 contrast
    T2 ´ëÁ¶µµ
  • gadolinium (Gd) based contrast agent
    °¡µ¹¸®´½ Á¶¿µÁ¦
  • good contrast
    ¶Ñ·ÇÇÑ ´ëÁ¶µµ
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pre-transfusion testing
    ¼öÇ÷Àü°Ë»ç
  • proficiency testing
    ¼÷·Ãµµ½ÃÇè
  • proteinuria testing
    ´Ü¹é´¢½ÃÇè
  • psychological testing
    ½É¸®°Ë»ç
  • reality testing
    Çö½Ç°ËÁ¤.
  • renal function testing
    ½Å±â´É°Ë»ç
  • sterility testing
    ¹«±Õ½ÃÇè
  • stress testing
    ºÎÇϽÃÇè(ݶùÃãËúÐ).
  • susceptibility testing
    °¨¼ö¼º½ÃÇè
  • two voltage testing technique
    ÀÌÀü¾Ð½ÃÇè¹ý
  • urine testing
    ¿ä°Ë»ç
  • cellular sensitivity
    ¼¼Æ÷°¨¼ö¼º
  • corneal sensitivity
    °¢¸·Áö°¢
  • diagnostic sensitivity
    Áø´ÜÀû ¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ°¨¼ö¼º°Ë»ç
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • contrast material
    Á¶¿µ ¹°Áú, Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
  • contrast to noise ratio
    ´ëÁ¶ÀâÀ½ºñ
  • double contrast arthrography
    ÀÌÁßÁ¶¿µ°üÀýÁ¶¿µ¼ú
  • double contrast radiography
    ÀÌÁßÁ¶¿µ¹æ»ç¼±ÃÔ¿µ¼ú
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • gadolinium based contrast agent
    °¡µ¹¸®´½Á¶¿µÁ¦
  • good contrast
    ¶Ñ·ÇÇÑ ´ëÁ¶µµ
  • hepato renal echo contrast
    °£½ÅÀå¿¡ÄÚ´ëÁ¶
  • magnetic transfer contrast [=MTC]
    ÀÚÈ­Àü´Þ´ëÁ¶µµ
  • negative contrast medium
    À½¼ºÁ¶¿µÁ¦
  • non-ionic contrast medium
    ºñÀ̿¼º Á¶¿µÁ¦
  • phase contrast
    À§»ó´ëÁ¶
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AMHT automated multiphasic health testing
ASTM American Society for Testing and Materials
DARTS Drug and Alcohol Rehabilitation Testing System
DAUs drug abuse testing and urines
ETS educational testing service; electrical transcranial stimulation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EST Exercise stress testing
ETT Exercise treadmill testing
FOBT Faecal occult blood testing
MMT Manual muscle testing
NAT Nucleic acid testing
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mechanical sensitivity
    ±â°èÀû °¨µµ
  • optimum sensitivity
    ÃÖÀû °¨µµ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å °¨¼ö¼º °Ë»ç
  • pain sensitivity
    µ¿Åë ¹Î°¨µµ
    µ¿Åë ¼ö¿ë±â´Â Ã˰¨À̳ª ¾Ð¹Ú°¨¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÏÁö ¾ÊÁö¸¸ Á¶Á÷À» ¼Õ»ó½Ãų Á¤µµÀÇ Ã˰¢¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÑ´Ù. µ¿Åë Àü´Þ°è´Â °¡²û µ¿Åë¿¡ °ú¹ÎÇÏ°Ô ¹ÝÀÀÇϴµ¥ À̸¦ µ¿Åë °ú¹ÎÁõÀ̶ó ÇÑ´Ù.
  • radiation sensitivity
    ¹æ»ç¼± °¨¼ö¼º
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º, ¹Î°¨¼ºµµ, °ú¹Î¼º
    °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
  • sensitivity disk method
    °¨¼ö¼º µð½ºÅ©¹ý
  • sensitivity range
    ¹Î°¨µµ ¹üÀ§
  • sensitivity test
    °¨µµ °Ë»ç, °¨µµ ½ÃÇè, °¨¼ö ½ÃÇè, °¨¼ö¼º ½ÃÇè, °¨¼ö¼º °Ë»ç
    ±ÕÀÇ È­ÇÐ ¿ä¹ýÁ¦¿¡ ´ëÇÑ °¨¼ö¼ºÀ» Á¶»çÇÏ¿© ±× °á°ú¿¡ À¯È¿ÇÑ ¾àÁ¦¸¦ ¼±ÅÃÇϱâ À§ÇØ ½Ç½ÃÇÏ´Â °Ë»ç.
  • sensitivity to touch of the scalp
    µÎÇÇ Á¢ÃË ½ÃÀÇ °ú¹Î¼º
  • spectral sensitivity
    ºÐ±¤ °¨µµ, ½ºÆåÆ®·³ ¹Î°¨µµ
  • barium contrast medium
    ¹Ù·ý Á¶¿µÁ¦
  • binocular contrast
    ¾ç ¾È ´ëºñ
  • contrast
    ´ëÁ¶µµ, ´ëÁ¶¹ý, ´ëºñ
    ÁÖÀ§ ¶Ç´Â ¾ÈÂÊ¿¡ µé¾îÀÖ´Â ¸Å°³ ¹°Áú, ±×¸®°í ´ëÁ¶ ¸ÅÁú°ú ÁÖÀ§ Á¶Á÷¿¡ ÀÇÇÑ x¼±ÀÇ Èí¼ö¿¡¼­ÀÇ Â÷ÀÌ ¶§¹®¿¡ »ý±ä´Ù. ±¸Á¶ÀÇ ¹æ»ç¼±Àû ½Ã°¢È­ÀÌ´Ù.
  • contrast color
    ´ëºñ»ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
acquired sensitivity 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy.
The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury.
2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders.
(18 Nov 1997)
analytical sensitivity The degree of response to a change in concentration of analyte being measured in an assay; synonymous with the detection limit.
(05 Mar 2000)
antibiotic sensitivity Microbial susceptibility to antibiotics.
See: antibiotic sensitivity test, minimal inhibitory concentration.
(05 Mar 2000)
antibiotic sensitivity test The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy.
(05 Mar 2000)
pacemaker sensitivity The minimum cardiac activity required to consistently trigger a pulse generator.
(05 Mar 2000)
relative sensitivity The sensitivity of a medical screening test as determined by comparison with the same type of test; e.g., sensitivity of a new serological test relative to sensitivity of an established serological test.
(05 Mar 2000)
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
microbial sensitivity tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
(12 Dec 1998)
photoallergic sensitivity See: photosensitization.
(05 Mar 2000)
phototoxic sensitivity See: photosensitization.
(05 Mar 2000)
clinical sensitivity Test positivity in disease; ability of a test to correctly identify disease.
See: diagnostic sensitivity.
(05 Mar 2000)
multiple chemical sensitivity An acquired disorder characterised by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses far below those established in the general population to cause harmful effects. No single widely accepted test of physiologic function can be shown to correlate with symptoms. (cullen mr. The worker with multiple chemical sensitivities: an overview. Occup med 1987;2(4):655-61)
(12 Dec 1998)
mumps sensitivity test A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen.
(05 Mar 2000)
contact sensitivity Allergic response to contact with irritant, usually a hypersensitivity.
(18 Nov 1997)
primaquine sensitivity Nonimmunological inborn sensitivity to primaquine, causing haemolysis on exposure to the drug, due to deficiency of glucose-6-phosphate dehydrogenase in red cells.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á